Monopar Therapeutics(MNPR.US)

Event Tracking

Dec29

Monopar Therapeutics CFO Buys Company Shares

17:16

Nov14

Monopar Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4825 (forecast USD -0.4345)

04:00

Monopar Therapeutics released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 0 and actual EPS of USD -1.2088

04:00

Oct10

Monopar Therapeutics Receives Buy Rating After Acquiring ALXN1840

11:46

Oct9

Analyst Kluska Maintains Strong Buy Rating on Monopar Therapeutics Inc

12:11

Oct2

Argyrides and BTIG Maintain Buy Rating on Monopar Therapeutics

12:21

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.438 M, EPS -0.4825

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.454 M, EPS -0.3505

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -2.625 M, EPS -0.3756

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change